110 related articles for article (PubMed ID: 11475165)
1. Prevalence of hepatitis C virus infection among clients of HIV counseling and testing sites--Connecticut, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Jul; 50(27):577-81. PubMed ID: 11475165
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.
Pereira GA; Stefani MM; Martelli CM; Turchi MD; Siqueira EM; Carneiro MA; Martins RM
J Med Virol; 2006 Jun; 78(6):719-23. PubMed ID: 16628586
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
4. [Detection of HCV infection among clients of an anonymous testing center for HIV infection].
Chlabicz S; Rogowska-Szadkowska D; Sokolowska M; Bułhak V; Ostaszewska-Puchalska I; Pytel-Krolczuk B; Puciło K
Przegl Epidemiol; 2005; 59(1):21-9. PubMed ID: 16013406
[TBL] [Abstract][Full Text] [Related]
5. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
[TBL] [Abstract][Full Text] [Related]
10. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
11. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.
Backmund M; Meyer K; Henkel C; Reimer J; Wächtler M; Schütz CG
Eur Addict Res; 2005; 11(3):138-44. PubMed ID: 15990431
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
Jindal N; Arora U; Singh K
Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area.
Bräu N; Bini EJ; Shahidi A; Aytaman A; Xiao P; Stancic S; Eng R; Brown ST; Paronetto F
Am J Gastroenterol; 2002 Aug; 97(8):2071-8. PubMed ID: 12190179
[TBL] [Abstract][Full Text] [Related]
15. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
Sungkanuparph S; Vibhagool A; Manosuthi W; Kiertiburanakul S; Atamasirikul K; Aumkhyan A; Thakkinstian A
J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
[TBL] [Abstract][Full Text] [Related]
17. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
18. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
19. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
Kresina TF; Bruce RD; Cargill VA; Cheever LW
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
[TBL] [Abstract][Full Text] [Related]
20. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]